A 3-month, multicenter, Investigator-Masked, Pilot Study to evaluate the eficacy and safety of Bimatoprost/Timolol fixed combination vs Latanoprost in treatment-Naive patients with Open-Angle Glaucoma at high risk of Glaucomatous progression. [more info]
An evaluation of the Ocular Surface Health in subjects using DuoTrav APS eye drops solution versus Xalacom® eye drops solution [more info]
Efficacy and safety assessment of T2345 unpreserved eyedrops versus Xalatan® in ocular hypertensive or glaucomatous patients. [more info]
Efficacy and safety assessment of intracameral T2380 (fixed combination of lidocaine, phenylephrine and tropicamide) for anaesthesia and mydriasis in phacoemulsification cataract surgery [more info]
A multicenter, masked, randomized, sham-controlled, paired-eye comparison, 12-month (plus 12-month extension) study to evaluate the safety and effects on Retinal Structure and Visual Function of Brimonidine tartrate posterior segment drug delivery system (Brimonidine Tartrate PS DDS) applicator system in patients with Geographic atrophy from Age-related Macular Degeneration [more info]
A phase 3 Prospective, Randomized, Double-Masked, 12-week, parallel group Study evaluating the efficacy and safety of Latanoprost and Timolol in Pediatric subjects with Glaucoma [more info]
A randomized, double-masked, active controlled, phase 3 study of the efficacy, safety, and tolerability of repeated doses of intravitreal VEGF Trop-Eye in subjects with neovascular age-related [more info]
A phase 1, Open-Label study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated with Latanoprost 0,005% [more info]
An Exploratory, Multicenter, Patient-masked, Dose-escalation, Paired-eye Comparison, Sham-controlled, 6-Month (Plus 6-Month Extension) Study to Evaluate the Safety and Effects on Visual Function of 100ug, 200 ug, and 400 ug Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimonidine Tartrate PS DDS) Applicator System in Patients with Retinitis Pigmentosa [more info]
A Multicenter, Investigator-Masked, Parallel-Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0,1% Eyedrops Compared with Kerorolac 0,5% Eyedrops in Ocular Inflammation After Cataract Surgery [more info]